Furthermore, due to its anti-apoptotic and pro-“stemness” functions, JAG1 blockade epitomizes an alluring model for combination therapy orchestrated by standard chemotherapy as demonstrated in preclinical models of ovarian and pancreatic cancer and lymphoma20,21. The gene discussed is JAG1; the disease is familial pancreatic carcinoma.